This website is intended for US healthcare professionals only.

  • Contact Us
    • Contact BioCryst
    • Submit an Inquiry
    • Request a Grant or Sponsorship
    • Expanded-Access Program
  • Search Medical Information
BioCryst logo
  • Clinical Trials
  • Congresses
  • Publications
  • Disease State Information & Resources
    • Hereditary Angioedema (HAE)
      • HAE Overview
      • HAE Video Library
    • Netherton Syndrome (NS)
    • Diabetic Macular Edema (DME)
    • Complement-Mediated Diseases
BioCryst logo
  • BioCryst logo
  • Clinical Trials
  • Congresses
  • Publications
      • HAE Overview
      • HAE Video Library
    • Netherton Syndrome (NS)
    • Diabetic Macular Edema (DME)
    • Complement-Mediated Diseases
    • Contact BioCryst
    • Submit an Inquiry
    • Request a Grant or Sponsorship
    • Expanded-Access Program
  • Search Medical Information
  • Caregivers’ Role in Managing Hereditary Angioedema and Perceptions of Treatment-Related Burdens

    View Article

    biocryst

    February 12, 2025

    Hereditary Angioedema (HAE)

  • Patient Perspectives on the Treatment Burden of Injectable Medication for Hereditary Angioedema

    View Article

    biocryst

    February 12, 2025

    Hereditary Angioedema (HAE)

  • Insights into the Treatment Burden of Hereditary Angioedema in the Evolving Treatment Landscape

    View Article

    biocryst

    February 12, 2025

    Hereditary Angioedema (HAE)

  • Time Trade‑Off Utilities for Hereditary Angioedema Health and Caregiver States

    View Article

    biocryst

    February 12, 2025

    Hereditary Angioedema (HAE)

  • Hereditary angioedema in children: Review and practical perspective for clinical management

    View Article

    biocryst

    February 12, 2025

    Hereditary Angioedema (HAE)

  • Androgen transition and management of hereditary angioedema long-term prophylaxis in real life: a single-center case series

    View Article

    biocryst

    February 12, 2025

    Hereditary Angioedema (HAE)

  • Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema

    View Article

    biocryst

    February 12, 2025

    Hereditary Angioedema (HAE)

  • Letter to the editor: network meta-analysis for indirect comparison of lanadelumab and berotralstat for the treatment of hereditary angioedema

    View Article

    biocryst

    February 12, 2025

    Hereditary Angioedema (HAE)

  • Berotralstat (BCX7353): Structure-Guided Design of a Potent, Selective, and Oral Plasma Kallikrein Inhibitor to Prevent Attacks of Hereditary Angioedema (HAE)

    View Article

    biocryst

    February 12, 2025

    Hereditary Angioedema (HAE)

  • Hereditary Angioedema Patients Would Prefer Newer-Generation Oral Prophylaxis

    View Article

    biocryst

    February 12, 2025

    Hereditary Angioedema (HAE)

Previous Page
1 2 3 4 … 7
Next Page
BioCryst logo

2025 BioCryst Pharmaceuticals, Inc.
All Rights Reserved

  • Contact Us
  • Terms of Use
  • Privacy Notice
  • Site Map
Close

You are now leaving biocrystmedical.com.

BioCryst is not responsible for and has no control over the content of linked sites.

Stay on Site Continue

This website is intended for healthcare professionals practicing in the US.

Are you a US healthcare professional? If not, you will be redirected to biocryst.com.

No, I am not a US healthcare professional Yes, I am a US healthcare professional